Identification of PSA peptide mimotopes using phage display peptide library

Peptides

Volumn 32, Issue 6, 2011, Pages 1097-1102

  Shanmugam, Arulkumaran ^a   Suriano, Robert ^a   Chaudhuri, Devyani ^a   Rajoria, Shilpi ^a   George, Andrea ^a   Mittelman, Abraham ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Peptide mimotope; Phage display; Prostate cancer; PSA

Indexed keywords

HEAT SHOCK PROTEIN 70; PEPTIDE LIBRARY; PROSTATE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; WESTERN BLOTTING;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CANCER VACCINES; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 79957976511     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.04.018     Document Type: Article

References (28)

1. E.S. Antonarakis, M.A. Carducci, and M.A. Eisenberger Novel targeted therapeutics for metastatic castration-resistant prostate cancer Cancer Lett 291 2010 1 13
2. P.M. Arlen, J.L. Gulley, C. Parker, L. Skarupa, M. Pazdur, and D. Panicali randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer Clin Cancer Res 12 2006 1260 1269 (Pubitemid 43342517)
3. D.A. Armbruster Prostate-specific antigen: biochemistry, analytical methods, and clinical application Clin Chem 39 1993 181 195 (Pubitemid 23069671)
4. B.T. Ashok, L. David, Y.G. Chen, V.P. Garikapaty, B. Chander, and D. Kanduc Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer Int J Mol Med 11 2003 465 471
5. L.L. Bonnycastle, J.S. Mehroke, M. Rashed, X. Gong, and J.K. Scott Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage J Mol Biol 258 1996 747 762 (Pubitemid 26150878)
6. E.D. Crawford, M. Rosenblum, A.M. Ziada, and P.H. Lange Hormone refractory prostate cancer Urology 54 1999 1 7
7. B.D. Elzey, D.R. Siemens, T.L. Ratliff, and D.M. Lubaroff Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors Int J Cancer 94 2001 842 849 (Pubitemid 33032833)
8. M.D.L.L. Garcia-Hernandez, A. Gray, B. Hubby, O.J. Klinger, and W.M. Kast Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity Cancer Res 68 2008 861 869 (Pubitemid 351206764)
9. W.J. Gullick Production of antisera to synthetic peptides Methods Mol Biol 32 1994 389 399
10. G.G. Hillman, J.A. Triest, M.L. Cher, S.V. Kocheril, and B.R. Talati Prospects of immunotherapy for the treatment of prostate carcinoma - a review Cancer Detect Prev 23 1999 333 342 (Pubitemid 29311595)
11. J.W. Hodge, J. Schlom, S.J. Donohue, J.E. Tomaszewski, C.W. Wheeler, and B.S. Levine A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate Int J Cancer 63 1995 231 237
12. A. Jemal, M.M. Center, and E. Ward The convergence of lung cancer rates between blacks and whites under the age of 40, United States Cancer Epidemiol Biomarkers Prev 18 2009 3349 3352
13. C. Jolivet-Reynaud, A. Adida, S. Michel, G. Deléage, G. Paranhos-Baccala, and V. Gonin Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase J Med Virol 72 2004 385 395 (Pubitemid 38133979)
14. C. Jolivet-Reynaud, M. Lésenéchal, B. O'Donnell, L. Becquart, A. Foussadier, and F. Forge Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies J Med Virol 65 2001 241 249 (Pubitemid 32816693)
15. M. Kawada, H. Inoue, M. Arakawa, and D. Ikeda Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I Anticancer Res 28 2008 721 730 (Pubitemid 351578914)
16. R.J. Lechleider, P.M. Arlen, K.Y. Tsang, S.M. Steinberg, J. Yokokawa, and V. Cereda Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant Clin Cancer Res 14 2008 5284 5291
17. D.M. Lubaroff, B.R. Konety, B. Link, J. Gerstbrein, T. Madsen, and M. Shannon Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results Clin Cancer Res 15 2009 7375 7380
18. D.J. Marshall, L.R. San Mateo, K.A. Rudnick, S.G. McCarthy, M.C. Harris, and C. McCauley Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine Cancer Immunol Immunother 54 2005 1082 1094 (Pubitemid 41396813)
19. A.M. Miller, V. Ozenci, R. Kiessling, and P. Pisa Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer J Immunother 28 2005 389 395 (Pubitemid 40962333)
20. N.J. Nesslinger, A. Ng, K.Y. Tsang, T. Ferrara, J. Schlom, and J.L. Gulley A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients Clin Cancer Res 16 2010 4046 4056
21. Y. Niu, S. Yeh, H. Miyamoto, G. Li, S. Altuwaijri, and J. Yuan Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation Cancer Res 68 2008 7110 7119
22. M. Pakkala, A. Jylhäsalmi, P. Wu, J. Leinonen, U.H. Stenman, and H. Santa Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity J Pept Sci 10 2004 439 447 (Pubitemid 39089269)
23. D.R. Siemens, B.D. Elzey, D.M. Lubaroff, C. Bohlken, R.J. Jensen, and A.K. Swanson Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix J Immunol 166 2001 731 735 (Pubitemid 32060221)
24. A.A. Sinha, K.A. Hagen, R.K. Sibley, M.J. Wilson, C. Limas, and P.K. Reddy Analysis of fixation effects on immunohistochemical localization of prostatic specific antigen in human prostate J Urol 136 1986 722 727 (Pubitemid 16012521)
25. T.K. Takayama, B.A. McMullen, P.S. Nelson, M. Matsumura, and K. Fujikawa Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase Biochemistry 40 2001 15341 15348 (Pubitemid 33151949)
26. I.F. Tannock, D. Osoba, M.R. Stockler, D.S. Ernst, A.J. Neville, and M.J. Moore Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points J Clin Oncol 14 1996 1756 1764 (Pubitemid 26185452)
27. P. Wu, J. Leinonen, E. Koivunen, H. Lankinen, and U.H. Stenman Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity Eur J Biochem 267 2000 6212 6220
28. P. Wu, L. Zhu, U.H. Stenman, and J. Leinonen Immunopeptidometric assay for enzymatically active prostate-specific antigen Clin Chem 50 2004 125 129 (Pubitemid 38125708)